ISHARES TR - U.S. PHARMA ETF (IHE)

CUSIP: 464288836

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / U.S. PHARMA ETF
Total 13F shares
506,968
Share change
+20,194
Total reported value
$90,990,918
Price per share
$179.44
Number of holders
98
Value change
+$3,797,914
Number of buys
47
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP 464288836?
CUSIP 464288836 identifies IHE - ISHARES TR - U.S. PHARMA ETF in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2020

As of 31 Dec 2020, ISHARES TR - U.S. PHARMA ETF (IHE) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 506,968 shares. The largest 10 holders included MORGAN STANLEY, BROWN ADVISORY INC, ROYAL BANK OF CANADA, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, RAYMOND JAMES & ASSOCIATES, LPL Financial LLC, WELLS FARGO & COMPANY/MN, MURPHY CAPITAL MANAGEMENT INC, and Steward Partners Investment Advisory, LLC. This page lists 98 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.